Cygnos Biotech, LLC
Miami, FL
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 10650 SW 137th St, Miami, FL 33176, USA
- Website
- cygnosbiotech.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $1,397,164 |
| FY2025 | $204,493 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of the Army | $1,397,164 |
Contract awards
SBA capabilities narrative
CYGNOS BioTech, LLC is a U.S.-based small business biotechnology company specializing in the development of virus-agnostic, host-directed antiviral biologics for veterinary and future human use, aligned with One Health and biodefense priorities. The company applies protein biologic engineering, advanced analytical characterization, and AI-assisted structural modeling to enable safe, manufacturable antiviral candidates. CYGNOS leverages an integrated network of academic, CRO, and cGMP manufacturing partners to advance programs from early discovery through preclinical development, regulatory engagement, and pilot clinical evaluation.
Quick answers
Is Cygnos Biotech, LLC registered in SAM.gov?
Yes. Cygnos Biotech, LLC's SAM.gov registration is active through December 23, 2026.
What is Cygnos Biotech, LLC's CAGE code?
Cygnos Biotech, LLC's CAGE code is 8WQ76, and its Unique Entity ID (UEI) is PXYDY5CQJDM3.
How much has Cygnos Biotech, LLC received in federal contracts?
Federal contracts obligated $204,493 to Cygnos Biotech, LLC in fiscal year 2025 and $1,601,657 in fiscal years 2023 through 2027.
How does Cygnos Biotech, LLC rank among federal contractors?
Cygnos Biotech, LLC ranked #86 in PSC AN13 in FY2025.
What is Cygnos Biotech, LLC's most recent federal award?
Cygnos Biotech, LLC's most recent federal contract award is The purpose of this small business innovation research (SBIR) phase II contract is to show efficacy of anti-viral… (W911SR26CA003), from ACC Aberdeen Proving Ground, on February 2, 2026.
On GovTribe
See Cygnos Biotech, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors